Publications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (10)

2026

  1. PROA-COMPLEX: redefiniendo los programas de optimización del uso de antimicrobianos para mejorar los resultados clínicos en pacientes de alto riesgo con infecciones graves

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 39, Núm. 3, pp. 191-237

2025

  1. Infecciones en el paciente sometido a transplante de órgano sólido

    Manual de Patología Infecciosa en Urgencias (Estratagema), pp. 710-718

2024

  1. How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations

    Enfermedades infecciosas y microbiologia clinica (English ed.), Vol. 42, Núm. 8, pp. 442-452

2021

  1. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

    Clinical Microbiology and Infection

2020

  1. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 10, pp. 3342-3347

  2. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 438-443

  3. Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort

    American Journal of Transplantation, Vol. 20, Núm. 2, pp. 451-462

2018

  1. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: A prospective pilot study

    Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv6-iv12

  2. T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study

    Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv13-iv19

2013

  1. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis

    Clinical Infectious Diseases, Vol. 56, Núm. 9, pp. 1261-1268